Description
Dislipidemia mixta
PRINCIPIO ACTIVO: SULFATO DE MAGNESIO
Obinutuzumab 1000 mg
No administrar sin dilución y sin las condiciones adecuadas de preparación e infusión
Psoriasis en placas moderada a grave
KERAL 50MG 2ML INY AMP C3 CELULOSA Dislipidemia mixtaPRINCIPIO ACTIVO: DEXKETOPROFENO DOSIS: 2 ML FORMA FARMACUTICA: 3 SOLUCION INYECTABLE AMPOLLETA PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
